112 related articles for article (PubMed ID: 2196399)
1. Expression of ras oncogene p21 protein in esophageal squamous cell carcinoma.
Ruol A; Stephens JK; Michelassi F; Segalin A; Chiarelli S; Peracchia A; Skinner DB; Little AG
J Surg Oncol; 1990 Jul; 44(3):142-5. PubMed ID: 2196399
[TBL] [Abstract][Full Text] [Related]
2. Ras oncogene and the acquisition of metastasizing properties by rectal adenocarcinoma.
Michelassi F; Erroi F; Roncella M; Block GE
Dis Colon Rectum; 1989 Aug; 32(8):665-8. PubMed ID: 2666052
[TBL] [Abstract][Full Text] [Related]
3. Relationship between ras oncogene expression and clinical and pathological features of colonic carcinoma.
Michelassi F; Grad G; Erroi F; Roncella M; Romagnoli J; Handcock M
Hepatogastroenterology; 1990 Oct; 37(5):513-6. PubMed ID: 2253930
[TBL] [Abstract][Full Text] [Related]
4. Ras oncogene expression as a prognostic indicator in rectal adenocarcinoma.
Michelassi F; Vannucci LE; Montag A; Chappell R; Rodgers J; Block GE
J Surg Res; 1988 Jul; 45(1):15-20. PubMed ID: 3392989
[TBL] [Abstract][Full Text] [Related]
5. Ras p21 immunostaining in early stage squamous cervical carcinoma: relationship with lymph nodal involvement and 72 kDa-metalloproteinase index.
Garzetti GG; Ciavattini A; Lucarini G; Goteri G; Nictolis MD; Romanini C; Biagini G
Anticancer Res; 1998; 18(1B):609-13. PubMed ID: 9568185
[TBL] [Abstract][Full Text] [Related]
6. [Immunohistochemical studies of ras oncogene product p21 in human ovarian tumors].
Yaginuma Y; Yamashita K
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1409-16. PubMed ID: 2685141
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of the expression of ras oncogene product in non-small cell lung cancer.
Harada M; Dosaka-Akita H; Miyamoto H; Kuzumaki N; Kawakami Y
Cancer; 1992 Jan; 69(1):72-7. PubMed ID: 1309311
[TBL] [Abstract][Full Text] [Related]
8. The clinicopathological significance of p21 and p53 expression in esophageal squamous cell carcinoma: an analysis of 153 patients.
Lam KY; Law S; Tin L; Tung PH; Wong J
Am J Gastroenterol; 1999 Aug; 94(8):2060-8. PubMed ID: 10445528
[TBL] [Abstract][Full Text] [Related]
9. Ha-ras oncogene product in human oral squamous cell carcinoma.
Oku N; Shimada K; Itoh H
Kobe J Med Sci; 1989 Dec; 35(5-6):277-86. PubMed ID: 2699627
[TBL] [Abstract][Full Text] [Related]
10. Ras oncogene p21 levels parallel malignant potential of different human colonic benign conditions.
Michelassi F; Leuthner S; Lubienski M; Bostwick D; Rodgers J; Handcock M; Block GE
Arch Surg; 1987 Dec; 122(12):1414-6. PubMed ID: 3318757
[TBL] [Abstract][Full Text] [Related]
11. [Clinical significance of oncogene product expression in human lung cancer].
Dosaka-Akita H; Harada M; Miyamoto H; Kawakami Y
Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Aug; 30(8):1441-7. PubMed ID: 1331597
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of nuclear DNA content and expression of the ras oncogene product in lung cancer.
Miyamoto H; Harada M; Isobe H; Akita HD; Haneda H; Yamaguchi E; Kuzumaki N; Kawakami Y
Cancer Res; 1991 Dec; 51(23 Pt 1):6346-50. PubMed ID: 1657384
[TBL] [Abstract][Full Text] [Related]
13. p53 expression and p21 expression are mutually exclusive in esophageal squamous cell carcinoma.
Hamada M; Naomoto Y; Shirakawa Y; Yamatsuji T; Noma K; Motoki T; Nobuhisa T; Okawa T; Haisa M; Gunduz M; Matsuoka J; Tanaka N
Oncol Rep; 2004 Jan; 11(1):57-63. PubMed ID: 14654903
[TBL] [Abstract][Full Text] [Related]
14. RAS oncogene product expression in normal and malignant oral mucosa.
Freer E; Savage NW; Seymour GJ; Dunn TL; Lavin MF; Gardiner RA
Aust Dent J; 1990 Apr; 35(2):141-6. PubMed ID: 2189381
[TBL] [Abstract][Full Text] [Related]
15. Deregulated p21(WAF1) overexpression impacts survival of surgically resected esophageal squamous cell carcinoma patients.
Goan YG; Hsu HK; Chang HC; Chou YP; Chiang KH; Cheng JT
Ann Thorac Surg; 2005 Sep; 80(3):1007-16. PubMed ID: 16122475
[TBL] [Abstract][Full Text] [Related]
16. [Immunohistochemical study of cytokeratin in esophageal carcinoma: preliminary report].
Mio H; Kumasiro R; Ikenaga H; Maekawa T; Inutsuka S; Murayama H; Kikuchi M
Nihon Geka Gakkai Zasshi; 1989 May; 90(5):793. PubMed ID: 2477679
[No Abstract] [Full Text] [Related]
17. Expression and prognostic significance of PTEN product protein in patients with esophageal squamous cell carcinoma.
Tachibana M; Shibakita M; Ohno S; Kinugasa S; Yoshimura H; Ueda S; Fujii T; Rahman MA; Dhar DK; Nagasue N
Cancer; 2002 Apr; 94(7):1955-60. PubMed ID: 11932897
[TBL] [Abstract][Full Text] [Related]
18. Correlation between the expression of the P21 ras oncogene product and the biological behavior of bladder tumors.
Miao TJ; Wang Z; Sang N
Eur Urol; 1991; 20(4):307-10. PubMed ID: 1814747
[TBL] [Abstract][Full Text] [Related]
19. ras p21 immunohistochemical detection in human endometrial carcinomas.
Semczuk A; Miturski R; Baranowski W; Jakowicki JA
Gynecol Obstet Invest; 1997; 44(2):132-5. PubMed ID: 9286729
[TBL] [Abstract][Full Text] [Related]
20. ras oncogene product p21 expression and prognosis of human ovarian tumors.
Yaginuma Y; Yamashita K; Kuzumaki N; Fujita M; Shimizu T
Gynecol Oncol; 1992 Jul; 46(1):45-50. PubMed ID: 1634140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
